Phase 4 Vitiligo Trial, Recruiting (NCT05536856)

Phase 4 Vitiligo Trial, Recruiting NCT05536856 Sponsor: Al-Azhar University Condition: Vitiligo

Printed from Voxsanity (voxsanity.com.au) — NCT05536856 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Vitiligo

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with localized, stable vitiligo (a skin condition causing patches of lost skin color that is not spreading).
You are older than 10 years of age.
Your vitiligo patches have not changed or spread for at least 1 year.
You have not received any treatment for vitiligo in the 6 weeks before the study begins.
You are willing to agree to take part, sign a written consent form, and stay involved until the end of the follow-up period.

Who may not be able to join:

You have vitiligo patches on mucous membranes, such as inside the mouth or nose.
You have a condition called Koebner phenomenon, where new vitiligo patches appear in areas of skin that have been injured or irritated (confirm with trial site).
You have other serious health conditions that are not well controlled.
You are currently receiving any treatment for vitiligo, whether taken by mouth/injection or applied to the skin.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +201069482380

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05536856

Sponsor: Al-Azhar University

Phase: Phase 4

Status: Recruiting

Condition: Vitiligo

Trial contact: +201069482380

More information: https://clinicaltrials.gov/study/NCT05536856

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with localized, stable vitiligo (a skin condition causing patches of lost skin color that is not spreading).
You are older than 10 years of age.
Your vitiligo patches have not changed or spread for at least 1 year.
You have not received any treatment for vitiligo in the 6 weeks before the study begins.
You are willing to agree to take part, sign a written consent form, and stay involved until the end of the follow-up period.

Who may not be able to join:

You have vitiligo patches on mucous membranes, such as inside the mouth or nose.
You have a condition called Koebner phenomenon, where new vitiligo patches appear in areas of skin that have been injured or irritated (confirm with trial site).
You have other serious health conditions that are not well controlled.
You are currently receiving any treatment for vitiligo, whether taken by mouth/injection or applied to the skin.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Al-Azhar University

Registry

ClinicalTrials.gov

Start date

15 October 2022

Est. completion

30 December 2025

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Vitiligo Area Scoring Index ranged from -50 for very much worse to +50 for very much improved. Improvement means repigmentation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov